Researchers Identify Artemisia Compound to Fight Coronavirus
A study published on October 29, 2026, details how anabsinthin may inhibit the coronavirus main protease.
Updated on Oct. 29, 2026 in Botany
Live Poll
Should natural plant-based compounds be prioritized for development into new antiviral drugs?
Scientists have identified anabsinthin, a dimeric sesquiterpene lactone derived from Artemisia absinthium, as a potential inhibitor of the coronavirus main protease. The findings were detailed in a study published on October 29, 2026.
Why it matters
Natural products require integrated approaches to prioritize bioactive metabolites for future antiviral drug development. This research provides a computational foundation for identifying compounds that could effectively target viral replication proteins.
Researchers utilized molecular docking, ADMET predictions, and 100 ns molecular dynamics simulations to evaluate the compound. The complex demonstrated stable interactions with key Mpro residues, specifically Glu166 and Gln189.
The details
The team optimized ultrasound-assisted extraction to isolate the compound from Artemisia absinthium. Their results indicated that anabsinthin exhibits more favorable computational binding characteristics against the coronavirus main protease than absinthin.
Timeline
The findings were published in a study on October 29, 2026.
The Big Picture
This study advances the coronavirus main protease inhibition research program by identifying a novel plant-derived scaffold for drug discovery. The findings suggest a potential shift toward using dimeric sesquiterpene lactones as therapeutic targets.
While this study provides promising computational data, it does not currently change medical treatment protocols or the availability of antiviral drugs. Future breakthroughs in experimental assays could eventually lead to the development of new, plant-based therapeutic options.
The takeaway
Identifying specific compounds like anabsinthin through computational modeling helps narrow down vast libraries of natural products for laboratory testing. These methods serve as a critical bridge between botanical discovery and the clinical development of new antiviral treatments.
Further reading
Learn more about the latest developments in Botany.
More information
Read the full scientific study publication for more data on the research methodology.
Live Poll
Should natural plant-based compounds be prioritized for development into new antiviral drugs?
